Acute pediatric hyperammonemia: current diagnosis and management strategies

Código QR

Acute pediatric hyperammonemia: current diagnosis and management strategies

Nadia Savy,1 David Brossier,2 Catherine Brunel-Guitton,1 Laurence Ducharme-Crevier,1 Geneviève Du Pont-Thibodeau,1 Philippe Jouvet1 1Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada; 2Department of Pediatrics, Pediatric Intensive Care Unit, CHU Ca...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Savy N, Brossier D, Brunel-Guitton C, Ducharme-Crevier L, Du Pont-Thibodeau G, Jouvet P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Pediatrics Critical Care hyperammonemia sodium phenylacetate sodium benzoate hemodialysis. Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/8f51fa196350445096f62770cdd57065
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Continuous Renal Replacement Therapy for Two Neonates With Hyperammonemia
por: Christopher Markham, et al.
Publicado: (2021)

Transmission, diagnosis, and management of hepatitis E: an update
por: Mirazo S, et al.
Publicado: (2014)

A Spy took a bite to get the diagnosis right: the benefit of SpyGlass technology in the diagnosis of autoimmune pancreatitis evading traditional diagnostic methods
por: Dianne Grunes, et al.
Publicado: (2021)

Pathological features and pathological diagnosis of drug-induced liver injury
por: YANG Yongfeng
Publicado: (2021)

Intrarectal Xyloglucan Administration Reduces Disease Severity in the Dextran Sodium Sulfate Model of Mouse Colitis
por: Ross EA, et al.
Publicado: (2021)

Clinical features of drug-induced liver failure and related diagnosis and treatment strategies
por: LAI Rongtao
Publicado: (2021)

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics
por: Dhanasekaran R, et al.
Publicado: (2012)

Impact of Diagnostic Delay on Disease Course in Pediatric Versus Adult-onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort
por: Alain M. Schoepfer, et al.
Publicado: (2021)

Acute hepatic failure in pediatric H1N1 infection: a case report from Al-Adan Hospital, Kuwait
por: Al-Refaee F
Publicado: (2012)

An excerpt of diagnosis, evaluation, and management of ascites and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
por: HU Jiaxuan
Publicado: (2021)

Unresectable hepatoblastoma: current perspectives
por: Trobaugh-Lotrario AD, et al.
Publicado: (2017)

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis
por: Mohammad Shehab, et al.
Publicado: (2021)

Impact of early cholecystectomy on the readmission rate in patients with acute gallstone cholangitis: a retrospective single-centre study
por: Bishnu Sapkota, et al.
Publicado: (2021)

Integrated real-time imaging system, ‘IRIS’, Kangaroo feeding tube: a guide to placement and image interpretation
por: Stephen Taylor, et al.
Publicado: (2021)

Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study
por: Peter M Irving, et al.
Publicado: (2021)

Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina
por: Espul C, et al.
Publicado: (2012)

Stopping anti-TNF in CD remitters: pros and cons
por: Edouard Louis
Publicado: (2021)

DEDICATED PSYCHIATRY CLINIC FOR INFLAMMATORY BOWEL DISEASE PATIENTS HAS A POSITIVE IMPACT ON DEPRESSION SCORES
por: Kaleb Bogale, et al.
Publicado: (2021)

Transarterial chemoembolization using iodized oil for unresectable hepatocellular carcinoma: perspective from multistep hepatocarcinogenesis
por: Yoshimitsu K
Publicado: (2014)

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
por: Suad Abdeen, et al.
Publicado: (2011)

New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
por: Chua DL, et al.
Publicado: (2014)

Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
por: Lim TR
Publicado: (2014)

Implementing Collaborative Care Management of Behavioral Health for Patients with Inflammatory Bowel Disease
por: Christine Beran, et al.
Publicado: (2021)

Update on entecavir in the management of severe forms of Hepatitis B
por: Sacco R
Publicado: (2012)

The Ratio of Platelets to Lymphocytes Predicts the Prognosis of Metastatic Colorectal Cancer: A Review and Meta-Analysis
por: Jinming Wang, et al.
Publicado: (2021)

CCR 3: Annual Meeting of the Clinical Research Development Unit of Shahid Rajaei Educational and Medical Center
por: Hossein Karim, et al.
Publicado: (2020)

Incidence of ‘new-onset’ constipation and associated factors during lockdown due to the COVID-19 pandemic
por: Bryan Adrian Priego-Parra, et al.
Publicado: (2021)

Organoid vs In Vivo Mouse Model: Which is Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
por: Shinya Sugimoto, MD, PhD, et al.
Publicado: (2022)

Rebuttal to: Organoid vs Mouse Model: Which is a Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
por: Jordi Guiu, PhD, et al.
Publicado: (2022)

CMGH: The year in review
por: Klaus H. Kaestner, PhD, MS, et al.
Publicado: (2021)

Contents
Publicado: (2021)

Form Follows Function for Local Immune Responses in Pancreatic Cancer
por: Anna L. Means, PhD
Publicado: (2021)

Myeloid Cell Mediated Immune Suppression in Pancreatic CancerSummary
por: Samantha B. Kemp, et al.
Publicado: (2021)

Cover 2 - Tertiary Lymphoid Structures: Hub for Pancreatic Cancer Immune Response
Publicado: (2021)

An Epigenetic Switch Between Differentiation and Proliferation in Hepatoblastoma
por: Jeffrey H. Albrecht, MD
Publicado: (2021)

Editorial Board
Publicado: (2021)

Rebuttal to: In Vivo Studies Should Take Priority When Defining Mechanisms of Intestinal Crypt Morphogenesis
por: Shinya Sugimoto, MD, PhD, et al.
Publicado: (2022)

In Vivo Studies Should Take Priority When Defining Mechanisms of Intestinal Crypt Morphogenesis
por: Jordi Guiu, PhD, et al.
Publicado: (2022)

Elsewhere in the AGA Journals
Publicado: (2021)

Crossing the Rubicon: Adipose Tissue Autophagy Breaks Out NAFLD
por: Jieun Kim, PHD, et al.
Publicado: (2021)